Journal of Environmental Treatment Techniques
2020, Volume 8, Issue 2, Pages: 708-717
researches on this concept and were able to purify it and enable
its public use. This vaccine provided the immunity rate of more
than 90% without causing any side effects (7). Router et al.
yeasts. Pichia pastoris was first identified as a high-performance
system in producing this antigen. In the first experiment, the
production rate reached to 48 mgHBsAg.L-1 culture 1 (12). At
the industrial scale, a change in the cell structure and use of
alcohol oxidase (AOX) gene promoter reduced the production
rate to 1.3mgHBsAg.L-1 culture. Phillips Co. signed a contract
with Salk Institute Biotechnology / Industrial Associates. Inc.
(1977) proposed making HBV vaccine through recombinant
technology. This production process could provide safe
abundant product. The first system was carried out by bacterial
cells, but experiments yielded no success (8). Before the
development of recombinant technology, the hepatitis B vaccine
was produced by extraction of hepatitis B surface antigen
(SIBIA) for the development of pichia pastoris as
a
microorganism for the expression of heterologous proteins in
1980. Researchers isolated AOX1 promoter in SIBIA and used it
as the promoter gene in manipulated pichia pastoris. AOX1 can
increase the total extract soluble protein up to 30% and methanol
grows merely in pichia pastoris (13-15). AOX1 enzyme is
responsible for the methanol of the first oxidation reaction in
pichia pastoris.It is synthesized by AOX1 promoter, which has
been widely used in the expression of recombinant proteins in
this microorganism (16-18). This expression system is widely
used for the expression of heterologous proteins (38). The
advantages of pichia pastoris compared to the saccharomyces
cerevisiae yeast include:
1. Pichia pastoris has a very active promoter for methanol
utilization and its oxidation to formaldehyde and hydrogen
peroxide and this activity is carried out by AOX enzyme.
2. The expression of this gene is highly regulated. In other
words, when it uses glucose or ethanol as the carbon source,
AOX is inactive. But when the yeast is cultured in medium
containing methanol, AOX can increase total cell proteins by
3% to 5%. There are 2 AOX genes, including AOX1 and AOX
2. AOX2 plays an inhibitory role for the expression.
(HBsAg), the main ingredient of hepatitis B vaccine, from the
plasma of infected patients (34, 37). Afterwards, Hall developed
this system by yeasts and Valenzuela et al. (1982) (7) managed
to achieve the first purified HBsAg product by recombinant
genetic system using yeasts. Finally, after nine years of research,
the first vaccine was made in 1986 and the US Food and Drug
Administration (FDA) issued the permission for its general use.
After a short while, French scientists were able to make the
same proteins that had the same ability to stimulate the immune
system. In this system, the recombinant plasmid was transferred
into ovary cells of a kind of Chinese mountain hamster mice.
This plasmid was a little different from the yeast plasmid
because it contained surplus of HBV genome. This means that in
addition to protein S gene, it also contained Pre-S2 protein gene.
Although this system was different from the yeast, it contained
same 22nm protein fragments that stimulated the immune
system.
1
.2 Saccharomyces cerevisiae
The first recombinant HBV vaccines, which can be
produced commercially, were made through genetic
manipulation of the yeasts. Normally after being made in
eukaryotic cells, proteins often enter the Golgi system to
undergo changes in their structure. For this reason, eukaryotic
cells such as yeast are used to produce the recombinant HBV
vaccine. A variety of yeasts that are used in the production of
recombinant HBV vaccine include: saccharomyces cerevisiae
and pichia pastoris. There were certain limitations associated
with the use of saccharomyces cerevisiae to produce HBV
vaccine, because its total protein efficiency (TPE) is 1% to 5%.
Also, placing a transgene in the yeast causes tensions in host
cells, and the produced foreign protein is considered toxic for
saccharomyces cerevisiae in many cases. Currently, P. pastoris
has attracted major attention in the healthcare industry for
efficient largescale production of recombinant products (34-36).
The first plasmid, in which hepatitis B antigen is produced under
the control of alcohol dehydrogenase gene promoter (ADH1),
was transformed in saccharomyces cerevisiae by Valenzuela et
al. This system has yielded an expression rate of about 10-25
μgHBsAg.L-1 culture(8). Later, the expression of this gene
reached to about 50 μgHBsAg.L-1 culture in saccharomyces
under the control of 3-phosphoglycerate kinase gene promoter
3. The use of methanol for this yeast leads to creation of a
special characteristics compared to other yeasts because
saccharomyces cerevisiae and most of other yeasts lack this
ability. Also, this yeast's ability to grow in the methanol can be
used to prevent contamination of the fermentation medium
during fermentation. Considering reasons mentioned above,
today, pichia pastoris has become a more suitable candidate for
use in the genetic engineering. To achieve an optimal strategy to
achieve the highest amount of recombinant protein production,
factors such as temperature, PH, specific growth rate of yeast
physiology, culture conditions and feed composition percentage
have been investigated.. Factors such as temperature have been
investigated frequently. Pichia pastoris fermentation process is
carried out in three ways: 1) Glycerol batch phase
2)Transformation phase (from development to production) 3)
Methanol induction phase and the induction phase was
investigated among the three above-mentioned phases.
1.3 Glycerol batch phase
The purpose of this phase is to obtain the maximum amount
of yeast in the shortest time. The highest µ in glycerol (1/h) has
been reported to be 0.18(19) that is much higher in comparison
with that of methanol (1 / h) (0.14) (20). Usually µ is much less
than this amount in methanol phase that is due to the production
of protein and negative impact of its metabolic burden on the
growth. This phase begins with glycerol concentration of 40g / L
independently of the type of pichia pastoris. Glycerol with
higher concentration acts as an inhibitor. Brierley et al. proposed
6% as the maximum amount for glycerol concentration (21).
Scientists measured the ethanol amount as about 2% in glycerol
concentration of above 7%. This ethanol concentration is toxic
to the yeast. The dry biomass obtained from this amount of
substrate is approximately 0.5. The amount of dry weight cells
(PGK) (9). Miyanohara et al. achieved expression rate of 2.8
μgHBsAg.L-1 culture under the control of acid phosphatase
gene promoter (10). Under the control of glyceraldehyde-3-
phosphate gene promoter (GPD), S gene expression rate reached
3
μgHBsAg.L-1 culture and about 20 culture mgHBsAg.L- 1 (6-
fold increase) in saccharomyces cerevisiae using the batch
fermentor and the batch-fed fermentor, respectively (11). The
fact that the cell can secrete the protein out of the cells is very
important. Chen et al. made a tremendous effort on this issue,
but it was useless (9). Due to problems associated with the
saccharomyces cerevisia use, researchers used methylotrophic
7
09